MediSapiens Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 14
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $1.86M
Latest Deal Amount
  • Investors
  • 7

MediSapiens General Information

Description

Operator of an adaptive technology platform intended to offer analysis, visualization, and management of multi-dimensional biologics data. The company's platform uses integrative multi-omics analysis, automated diagnostic workflows, empowered precision medicine programs, and other health data to improve human and veterinary health, enabling bio-oncologists to understand and analyze genomics data quickly, cost-effectively, and with minimum development risk.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Business/Productivity Software
Other Industries
Media and Information Services (B2B)
Other Healthcare Technology Systems
Other Healthcare Services
Primary Office
  • Vuorikatu 14, 5th floor
  • 00100 Helsinki
  • Finland
+358 045 0000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MediSapiens Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 21-Jan-2021 $1.86M 00.00 00.000 Completed Generating Revenue
6. Later Stage VC 14-Dec-2017 00000 00.000 00.000 Completed Generating Revenue
5. Later Stage VC 24-Oct-2016 00000 00.000 00.000 Completed Generating Revenue
4. Later Stage VC 11-Dec-2015 00.000 Completed Generating Revenue
3. Later Stage VC 16-Oct-2014 00.000 00.000 00.000 Completed Generating Revenue
2. Early Stage VC 10-Jan-2013 $1.32M Completed Startup
1. Seed Round 12-May-2010 $1.32M $1.32M 00.000 Completed Startup
To view MediSapiens’s complete valuation and funding history, request access »

MediSapiens Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
B Shares 0,000,000 00.00 00.00 00 00.00 00.000
B Shares 000,000 00.00 00.00 00 00.00 00.000
B Shares 0,000,000 00.00 00.00 00 00.00 00.00
B Shares 00,000 00.00 00.00 00 00.00 0.000
B Shares 00,000 00.00 00.00 00 00.00 0.000
A Shares 00,000 00.00 00.00 00 00.00 0.000
Ordinary 242,800 $5.64 $5.64 1x $5.64 4.77%
Ordinary 242,800 $5.01 $5.01 1x $5.01 4.77%
To view MediSapiens’s complete cap table history, request access »

MediSapiens Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of an adaptive technology platform intended to offer analysis, visualization, and management of multi-dimension
Business/Productivity Software
Helsinki, Finland
14 As of 2022
00.00
0.000 0000-00-00
0000000000 0 00.00

00000000

ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolor
00000 0000000000 00000000
New York, NY
00 As of 0000
00.00
0000000000 00.00

00000000

aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cil
00000 0000000000 0000000000 0000000
Victoria, Canada
00 As of 0000
000.00
000 0000-00-00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MediSapiens Competitors (26)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SolveBio Venture Capital-Backed New York, NY 00 00.00 0000000000 00.00
0000000000 Formerly VC-backed Victoria, Canada 00 000.00 000000&0 000.00
000000 Venture Capital-Backed Oakland, CA 00 000.00 000000000 - 000.00
000000 0000 000000 Formerly VC-backed Bangalore, India 000 000.00 000000&0 000.00
000000000 Venture Capital-Backed Creve Coeur, MO 000 000.00 0000000000 0 000.00
You’re viewing 5 of 26 competitors. Get the full list »

MediSapiens Patents

MediSapiens Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3066603-A4 Method and system for estimating genomic health Pending 04-Nov-2013 000000000 0
US-20160259882-A1 Method and system for estimating genomic health Abandoned 04-Nov-2013
EP-3066603-A1 Method and system for estimating genomic health Withdrawn 04-Nov-2013 000000000
US-20180181705-A1 Method, an arrangement and a computer program product for analysing a biological or medical sample Abandoned 12-Mar-2010
US-20130066860-A1 Method, an arrangement and a computer program product for analysing a biological or medical sample Granted 12-Mar-2010 G06F16/285 0
To view MediSapiens’s complete patent history, request access »

MediSapiens Executive Team (10)

Name Title Board Seat Contact Info
Nils Effertz Chief Executive Officer & Managing Director
Juho Pietilanaho Chief Financial Officer
Max Salmi Chief Operating Officer & Chief Technology Officer
Olli Kallioniemi Ph.D Co-Founder & Board Member
You’re viewing 4 of 10 executive team members. Get the full list »

MediSapiens Board Members (8)

Name Representing Role Since
Jonathan Knowles Self Board Member 000 0000
Olli Kallioniemi Ph.D MediSapiens Co-Founder & Board Member 000 0000
Pekka Simula Self Board Member 000 0000
Petri Laine Finnvera Chairman 000 0000
Steven Myint Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

MediSapiens Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MediSapiens Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Innovestor Venture Capital Minority 000 0000 000000 0
Tekes Not-For-Profit Venture Capital Minority 000 0000 000000 0
Verdane PE/Buyout Minority 000 0000 000000 0
Eqvitec Partners Venture Capital Minority 000 0000 000000 0
Finnvera Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »